Paul A. Harding

1.1k total citations
27 papers, 763 citations indexed

About

Paul A. Harding is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Paul A. Harding has authored 27 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Paul A. Harding's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Paul A. Harding is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Paul A. Harding collaborates with scholars based in United States, Australia and Canada. Paul A. Harding's co-authors include David R. Brigstock, J.R. Diehl, Ravindra K. Vegunta, John J. Kopchick, Gail E. Besner, Shigeru Okada, Srikumar Pillai, Nishith Bhattacharyya, Randolph K. Cribbs and Mark Luquette and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

Paul A. Harding

27 papers receiving 748 citations

Peers

Countries citing papers authored by Paul A. Harding

Since Specialization

Citations

This map shows the geographic impact of Paul A. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Harding more than expected).

Fields of papers citing papers by Paul A. Harding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Harding. The network helps show where Paul A. Harding may publish in the future.

Co-authorship network of co-authors of Paul A. Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Harding. A scholar is included among the top collaborators of Paul A. Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Harding. Paul A. Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate 2022 ·AIDS Research and Human Retroviruses ·(unknown), Kristina M. Brooks, Jennifer Brothers, Kathleen Mulligan, Raphael J. Landovitz, (unknown), (unknown), (unknown), Paul A. Harding, (unknown), Peter L. Anderson, Sybil Hosek	9
2	Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial 2017 ·PLoS ONE ·Allison L. Agwu, Meredith G. Warshaw, Elizabeth J. McFarland, George K. Siberry, Ann J. Melvin, Andrew Wiznia, Lee Fairlie, (unknown), Paul A. Harding, Hans Spiegel, Elaine J. Abrams, Vincent J. Carey, (unknown)	11
3	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): A regulator of several pathways 2014 ·Seminars in Cell and Developmental Biology ·(unknown), (unknown), Paul A. Harding	48
4	Cellular reprogramming into a brown adipose tissue-like phenotype by co-expression of HB-EGF and ADAM 12S 2013 ·Growth Factors ·(unknown), (unknown), (unknown), (unknown), (unknown), Paul A. Harding	3
5	Transmembrane and Soluble Isoforms of Heparin-Binding Epidermal Growth Factor–Like Growth Factor Regulate Distinct Processes in the Pancreas 2009 ·Gastroenterology ·Kevin C. Ray, Stacy A. Blaine, M. Kay Washington, Ada Braun, Amar Singh, Raymond C. Harris, Paul A. Harding, Robert J. Coffey, Anna L. Means	12
6	Planned Multiple Exposures to Autologous Virus in HIV Type 1-Infected Pediatric Populations Increases HIV-Specific Immunity and Reduces HIV Viremia 2008 ·AIDS Research and Human Retroviruses ·William Borkowsky, Ram Yogev, Petronella Muresan, Elizabeth J. McFarland, Lisa M. Frenkel, Terry Fenton, Edmund V. Capparelli, Jack Moye, Paul A. Harding, (unknown), Barbara Heckman, Joyce Kraimer	9
7	The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach 2008 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Paul A. Harding	2
8	Amino‐terminal deletion of heparin‐binding epidermal growth factor‐like growth factor₄₋₁₂₇ stimulates cell proliferation but lacks insulin‐like activity 2007 ·Cell Proliferation ·(unknown), Paul A. Harding	5
9	Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA 2005 ·Growth Factors ·(unknown), Gail E. Besner, Paul F. James, Paul A. Harding	13
10	Clonal CD8⁺T Cell Expansions in Peripheral Blood from Human Immunodeficiency Virus Type 1–Infected Children 2002 ·The Journal of Infectious Diseases ·Elizabeth J. McFarland, Paul A. Harding, Christopher C. Striebich, Samantha MaWhinney, Daniel R. Kuritzkes, Brian L. Kotzin	7
11	Induction of Anchorage Independent Growth by Heparin-binding EGF-like Growth Factor (HB-EGF) 1999 ·Growth Factors ·Paul A. Harding, (unknown), (unknown), Matthew T. Miller, David R. Brigstock, Gail E. Besner	18
12	In Vitro Effects of IL-12 on HIV-1-Specific CTL Lines from HIV-1-Infected Children 1998 ·The Journal of Immunology ·Elizabeth J. McFarland, Paul A. Harding, Samantha MaWhinney, Robert T. Schooley, Daniel R. Kuritzkes	17
13	Characterization of Pig Connective Tissue Growth Factor (CTGF) cDNA, mRNA and Protein from Uterine Tissue 1998 ·DNA sequence ·Paul A. Harding, Gulnar A. Surveyor, David R. Brigstock	16
14	Characterization of Cell-Associated and Soluble Forms of Connective Tissue Growth Factor (CTGF) Produced by Fibroblast CellsIn Vitro 1998 ·Growth Factors ·(unknown), (unknown), Paul A. Harding, Nishith Bhattacharyya, Srikumar Pillai, David R. Brigstock	111
15	Purification and Characterization of Novel Heparin-binding Growth Factors in Uterine Secretory Fluids 1997 ·Journal of Biological Chemistry ·David R. Brigstock, (unknown), (unknown), Ravindra K. Vegunta, J.R. Diehl, Paul A. Harding	180
16	Characterization of the gene encoding murine heparin-binding epidermal growth factor-like growth factor 1996 ·Gene ·Paul A. Harding, David R. Brigstock, (unknown), (unknown), Gail E. Besner	8
17	Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization 1996 ·Journal of Biological Chemistry ·Paul A. Harding, Xinzhong Wang, Shigeru Okada, Wen Y. Chen, (unknown), John J. Kopchick	72
18	Cloning of a pig glucose transporter 4 cDNA fragment: use in developing a sensitive ribonuclease protection assay for quantifying low-abundance glucose transporter 4 mRNA in porcine adipose tissue 1994 ·Journal of Animal Science ·Percy Chiu, Surabhi Chaudhuri, Paul A. Harding, John J. Kopchick, Shawn S. Donkin, Terry D. Etherton	9
19	In vitro mutagenesis of growth hormone receptor Asn-linked glycosylation sites 1994 ·Molecular and Cellular Endocrinology ·Paul A. Harding, (unknown), Bruce Kelder, Sandra C. Souza, Shigeru Okada, John J. Kopchick	39
20	Expression of a functional porcine growth hormone receptor cDNA in mouse L cells 1993 ·Molecular and Cellular Endocrinology ·(unknown), (unknown), Bruce Kelder, Paul A. Harding, Wen Y. Chen, John J. Kopchick	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact